This article refers to:
In the Review entitled “New generation azole antifungals in clinical investigation”; by Corrado Girmenia, published in the September 2009 issue of Expert Opinion on Investigational Drug (Expert Opin. Investig. Drugs (2009) 18(9):1279-1295), it has been brought to our attention that the declaration of interest should have read as follows:
C Girmenia has received honoraria from and been a speaker for Schering-Plough (the producer of posaconazole) and Pfizer Pharmaceuticals (the producer of fluconazole and voriconazole).
The authors, editors and publisher sincerely regret any inconvenience this may have caused our readers.